Neural mechanisms of placebo anxiolysis

Journal of Neuroscience

Volumn 35, Issue 19, 2015, Pages 7365-7373

  Meyer, Benjamin ^a,b   Yuen, Kenneth S L ^a,b   Ertl, Matthias ^a,c   Polomac, Nenad ^a   Mulert, Christoph ^a   Büchel, Christian ^a   Kalisch, Raffael ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anxiety; EEG; Event related potentials; Frontal midline theta; Placebo effect

Indexed keywords

LORAZEPAM; PLACEBO;

ADULT; ALERTNESS; ANXIETY; ARTICLE; BEHAVIORAL RESEARCH; COGNITION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; ELECTRODERMAL RESPONSE; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGICAL PROCEDURES; ENVIRONMENTAL FACTOR; EVENT RELATED POTENTIAL; FEMALE; HUMAN; MALE; PLACEBO EFFECT; PRIORITY JOURNAL; SCORING SYSTEM; TRANQUILIZING ACTIVITY; VISUAL ANALOG SCALE; ADVERSE EFFECTS; ASSOCIATION; BRAIN; BRAIN MAPPING; COMPLICATION; ELECTROSTIMULATION; FEAR; MIDDLE AGED; NORMAL HUMAN; PAIN; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PSYCHOLOGY; THERAPY; TIME; YOUNG ADULT;

ADULT; ANXIETY; BRAIN; BRAIN MAPPING; CUES; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; FEAR; FEMALE; GALVANIC SKIN RESPONSE; HEALTHY VOLUNTEERS; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PLACEBO EFFECT; PLACEBOS; TIME FACTORS; YOUNG ADULT;

EID: 84929379127     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4793-14.2015     Document Type: Article

References (69)

1. Aftanas LI, Golocheikine SA (2001) Human anterior and frontal midline theta and lower alpha reflect emotionally positive state and internalized attention: high-resolution EEG investigation of meditation. Neurosci Lett 310:57-60. CrossRef Medline
2. Amanzio M, Benedetti F, Porro CA, Palermo S, Cauda F (2013) Activation likelihood estimation meta-analysis of brain correlates of placebo analgesia in human experimental pain. Hum Brain Mapp 34:738-752.
3. Anguera JA, Boccanfuso J, Rintoul JL, Al-Hashimi O, Faraji F, Janowich J, Kong E, Larraburo Y, Rolle C, Johnston E, Gazzaley A (2013) Video game training enhances cognitive control in older adults. Nature 501:97-101. CrossRef Medline
4. Baas JM, Kenemans JL, Böcker KB, Verbaten MN (2002) Threat-induced cortical processing and startle potentiation. Neuroreport 13:133-137. CrossRef Medline
5. Benedek M, Kaernbach C (2010) A continuous measure of phasic electro-dermal activity. JNeurosci Methods 190:80-91. CrossRef Medline
6. Benedetti F (2010) No prefrontal control, no placebo response. Pain 148: 357-358. CrossRef Medline
7. Benedetti F, Maggi G, Lopiano L, Lanotte M, Rainero I, Vighetti S, Polio A (2003) Open versus hidden medical treatments: the patient's knowledge about a therapy affects the therapy outcome. Prev Treat 6. CrossRef
8. Benedetti F, Colloca L, Torre E, Lanotte M, Melcarne A, Pesare M, Bergam-asco B, Lopiano L (2004) Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat Neurosci 7:587-588. CrossRef Medline
9. Benedetti F, Carlino E, Polio A (2011) How placebos change the patient's brain. Neuropsychopharmacology 36:339-354. CrossRef Medline
10. Bingel U, Lorenz J, Schoell E, Weiller C, Büchel C (2006) Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 120:8-15. CrossRef Medline
11. Blanchard RJ, Yudko EB, Rodgers RJ, Blanchard DC (1993) Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety. Behav Brain Res 58:155-165. CrossRef Medline
12. Boucsein W, Fowles DC, Grimnes S, Ben-Shakhar G, Roth WT, Dawson ME, Filion DL, Society for Psychophysiological Research Ad Hoc Committee on Electrodermal Measures (2012) Publication recommendations for electrodermal measurements. Psychophysiology 49:1017-1034. CrossRef Medline
13. Brookhuis KA, Mulder G, Mulder LJ, Gloerich AB, van Dellen HJ, van der Meere JJ, Ellermann H (1981) Late positive components and stimulus evaluation time. Biol Psychol 13:107-123. CrossRef Medline
14. Büchel C, Morris J, Dolan RJ, Friston KJ (1998) Brain systems mediating aversive conditioning: an event-related fMRI study. Neuron 20:947-957. CrossRef Medline
15. Büchel C, Geuter S, Sprenger C, Eippert F (2014) Placebo analgesia: a predictive coding perspective. Neuron 81:1223-1239. CrossRef Medline
16. Colloca L, Lopiano L, Lanotte M, Benedetti F (2004) Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol 3:679-684. CrossRef Medline
17. Cooper NR, Croft RJ, Dominey SJ, Burgess AP, Gruzelier JH (2003) Paradox lost? Exploring the role of alpha oscillations during externally vs. internally directed attention and the implications for idling and inhibition hypotheses. Int J Psychophysiol 47:65-74. CrossRef Medline
18. Davis M, Walker DL, Miles L, Grillon C (2010) Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 35:105-135. CrossRef Medline
19. Di Russo F, Martinez A, Sereno MI, Pitzalis S, Hillyard SA (2002) Cortical sources of the early components of the visual evoked potential. Hum Brain Mapp 15:95-111. CrossRef Medline
20. Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, Büchel C (2009) Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 63:533-543. CrossRef Medline
21. Ertl M, Hildebrandt M, Ourina K, Leicht G, Mulert C (2013) Emotion regulation by cognitive reappraisal: the role of frontal theta oscillations. Neuroimage 81:412-421. CrossRef Medline
22. Fanselow MS, Lester LS (1988) A functional behavioristic approach to aver-sively motivated behavior: predatory imminence as a determinant of the topography of defensive behavior. In: Evolution and learning (Bolles RC, Beecher MD, eds), pp 185-211. Hillsdale, NJ: Erlbaum.
23. Flaten MA, Aslaksen PM, Lyby PS, Bjørkedal E (2011) The relation of emotions to placebo responses. Philos Trans R Soc Lond B Biol Sci 366:1818-1827. CrossRef Medline
24. Furmark T, Appel L, Henningsson S, Ahs F, Faria V, Linnman C, Pissiota A, Frans O, Bani M, Bettica P, Pich EM, Jacobsson E, Wahlstedt K, Oreland L, Långström B, Eriksson E, Fredrikson M (2008) A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. J Neurosci 28:13066-13074. CrossRef Medline
25. Gevins A, Smith ME, McEvoy L, Yu D (1997) High-resolution EEG mapping of cortical activation related to working memory: effects of task difficulty, type of processing, and practice. Cereb Cortex 7:374-385. CrossRef Medline
26. Grillon C (2008) Models and mechanisms of anxiety: evidence from startle studies. Psychopharmacology (Berl) 199:421-437. CrossRef Medline
27. Gross JJ (1998) Antecedent-and response-focused emotion regulation: divergent consequences for experience, expression, and physiology. J Pers Soc Psychol 74:224-237. CrossRef Medline
28. Hajcak G, MacNamara A, Olvet DM (2010) Event-related potentials, emotion, and emotion regulation: an integrative review. Dev Neuropsychol 35:129-155. CrossRef Medline
29. Hsieh LT, Ranganath C (2014) Frontal midline theta oscillations during working memory maintenance and episodic encoding and retrieval. Neuroimage 85:721-729. CrossRef Medline
30. Hsieh LT, Ekstrom AD, Ranganath C (2011) Neural oscillations associated with item and temporal order maintenance in working memory. J Neurosci 31:10803-10810. CrossRef Medline
31. Huber PJ (1981) Robust statistics. New York: Wiley.
32. Isreal JB, Wickens CD, Chesney GL, Donchin E (1980) The event-related brain potential as an index of display-monitoring workload. Hum Factors 22:211-224. Medline
33. Johnson R Jr (1984) P300: a model of the variables controlling its amplitude. Ann N Y Acad Sci 425:223-229. CrossRef Medline
34. Klimesch W, Sauseng P, Hanslmayr S (2007) EEG alpha oscillations: the inhibition-timing hypothesis. Brain Res Rev 53:63-88. CrossRef Medline
35. Kok A (2001) On the utility of P3 amplitude as a measure of processing capacity. Psychophysiology 38:557-577. CrossRef Medline
36. Kolassa IT, Musial F, Mohr A, Trippe RH, Miltner WH (2005) Electrophys-iological correlates of threat processing in spider phobics. Psychophysiology 42:520-530. CrossRef Medline
37. Krummenacher P, Candia V, Folkers G, Schedlowski M, Schönbächler G (2010) Prefrontal cortex modulates placebo analgesia. Pain 148:368-374. CrossRef Medline
38. Lachaux JP, Rodriguez E, Martinerie J, Varela FJ (1999) Measuring phase synchrony in brain signals. Hum Brain Mapp 8:194-208. CrossRef Medline
39. Leuchter AF, Cook I A, Witte EA, Morgan M, Abrams M (2002) Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry 159:122-129. CrossRef Medline
40. Liu Y, Huang H, McGinnis-Deweese M, Keil A, Ding M (2012) Neural substrate of the late positive potential in emotional processing. J Neurosci 32:14563-14572. CrossRef Medline
41. Lykken DT, Venables PH (1971) Direct measurement of skin conductance: a proposal for standardization. Psychophysiology 8:656-672. CrossRef Medline
42. Magliero A, Bashore TR, Coles MG, Donchin E (1984) On the dependence of P300 latency on stimulus evaluation processes. Psychophysiology 21: 171-186. CrossRef Medline
43. Maris E, Oostenveld R (2007) Nonparametric statistical testing of EEG-and MEG-data. J Neurosci Methods 164:177-190. CrossRef Medline
44. Mobbs D, Petrovic P, Marchant JL, Hassabis D, Weiskopf N, Seymour B, Dolan RJ, Frith CD (2007) When fear is near: threat imminence elicits prefrontal-periaqueductal gray shifts in humans. Science 317:1079-1083. CrossRef Medline
45. Mulert C, Jäger L, Schmitt R, Bussfeld P, Pogarell O, Möller HJ, Juckel G, Hegerl U (2004) Integration of fMRI and simultaneous EEG: towards a comprehensive understanding of localization and time-course of brain activity in target detection. Neuroimage 22:83-94. CrossRef Medline
46. Nitzan U, Lichtenberg P (2004) Questionnaire survey on use of placebo. BMJ 329:944-946. CrossRef Medline
47. Nunez PL, Srinivasan R, Westdorp AF, Wijesinghe RS, Tucker DM, Silberstein RB, Cadusch PJ (1997) EEG coherency. I: Statistics, reference electrode, volume conduction, Laplacians, cortical imaging, and interpretation at multiple scales. Electroencephalogr Clin Neurophysiol 103:499-515. CrossRef Medline
48. Ochsner KN, Gross JJ (2005) The cognitive control of emotion. Trends Cogn Sci 9:242-249. CrossRef Medline
49. Oostenveld R, Fries P, Maris E, Schoffelen JM (2011) FieldTrip: open source software for advanced analysis of MEG, EEG, and invasive electrophysi-ological data. Comput Intell Neurosci 2011:156869. CrossRef Medline
50. Petrovic P, Dietrich T, Fransson P, Andersson J, Carlsson K, Ingvar M (2005) Placebo in emotional processing: induced expectations of anxiety relief activate a generalized modulatory network. Neuron 46:957-969. CrossRef Medline
51. Pfurtscheller G, Stancák A Jr, Neuper C (1996) Event-related synchronization (ERS) in the alpha band-an electrophysiological correlate of cortical idling: a review. Int J Psychophysiol 24:39-46. CrossRef Medline
52. Polich J (2007) Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol 118:2128-2148. CrossRef Medline
53. Polich J, Kok A (1995) Cognitive and biological determinants of P300: an integrative review. Biol Psychol 41:103-146. CrossRef Medline
54. Price DD, Finniss DG, Benedetti F (2008) A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol 59:565-590. CrossRef Medline
55. Rodgers RJ (1997) Animal models of "anxiety": where next? Behav Pharmacol 8:477-496; discussion 497-504. CrossRef Medline
56. Sauseng P, Hoppe J, Klimesch W, Gerloff C, Hummel FC (2007) Dissociation of sustained attention from central executive functions: local activity and interregional connectivity in the theta range. Eur J Neurosci 25:587-593. CrossRef Medline
57. Scharmüller W, Leutgeb V, Schäfer A, Köchel A, Schienle A (2011) Source localization of late electrocortical positivity during symptom provocation in spider phobia: an sLORETA study. Brain Res 1397:10-18. CrossRef Medline
58. Scharmüller W, Leutgeb V, Schäfer A, Schienle A (2012) Investigating phobic specificity with standardized low resolution brain electromagnetic tomography (sLORETA). Brain Res 1477:74-82. CrossRef Medline
59. Schienle A, Übel S, Scharmüller W (2014) Placebo treatment can alter primary visual cortex activity and connectivity. Neuroscience 263:125-129. CrossRef Medline
60. Schmidt L, Braun EK, Wager TD, Shohamy D (2014) Mind matters: placebo enhances reward learning in Parkinson's disease. Nat Neurosci 17:1793-1797. CrossRef Medline
61. Sherman R, Hickner J (2008) Academic physicians use placebos in clinical practice and believe in the mind-body connection. J Gen Intern Med 23:7-10. CrossRef Medline
62. Spielberger C (1985) Assessment of state and trait anxiety: conceptual and methodological issues. Southern Psychol 2:6-16.
63. Stein DJ, Baldwin DS, Dolberg OT, Despiegel N, Bandelow B (2006) Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram. J Clin Psychiatry 67:1741-1746. CrossRef Medline
64. Sugarman MA, Loree AM, Baltes BB, Grekin ER, Kirsch I (2014) The efficacy of paroxetine and placebo in treating anxiety and depression: a metaanalysis of change on the Hamilton Rating Scales. PLoS One 9:e 106337. CrossRef Medline
65. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, Kosslyn SM, Rose RM, Cohen JD (2004) Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 303:1162-1167. CrossRef Medline
66. Walker DL, Toufexis DJ, Davis M (2003) Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol 463:199-216. CrossRef Medline
67. Weymar M, Bradley MM, Hamm AO, Lang PJ (2013) When fear forms memories: threat of shock and brain potentials during encoding and recognition. Cortex 49:819-826. CrossRef Medline
68. Zahn TP, Rapoport JL, Thompson CL (1981) Autonomic effects of dextroamphetamine in normal men: implications for hyperactivity and schizophrenia. Psychiatry Res 4:39-47. CrossRef Medline
69. Zhang W, Qin S, Guo J, Luo J (2011) A follow-up fMRI study of a transferable placebo anxiolytic effect. Psychophysiology 48:1119-1128. CrossRef Medline